Journal article
Rivaroxaban for treatment of suspected or confirmed heparin‐induced thrombocytopenia study
Abstract
Essentials Heparin-induced thrombocytopenia (HIT) is a thrombogenic condition that is difficult to treat. We evaluated rivaroxaban as a treatment option in patients with suspected or confirmed HIT. One patient had recurrent thrombosis and 9/10 patients with thrombocytopenia had platelet recovery. Rivaroxaban may be an effective and safe treatment option for HIT.
SUMMARY: Background Rivaroxaban is a direct oral anti-Xa inhibitor that has the …
Authors
Linkins LA; Warkentin TE; Pai M; Shivakumar S; Manji RA; Wells PS; Wu C; Nazi I; Crowther MA
Journal
Journal of Thrombosis and Haemostasis, Vol. 14, No. 6, pp. 1206–1210
Publisher
Elsevier
Publication Date
June 2016
DOI
10.1111/jth.13330
ISSN
1538-7933